rising at a CAGR of 10.15% The global pharmaceutical R&D outsourcing market report consists of exclusive data on 44 vendors. Major players like Boehringer Ingelheim, Charles River Laboratories ...

The global pharmaceutical market size was valued at USD 1,607.07 billion in 2024 ... Technologies like artificial intelligence (AI), machine learning, big data analytics, and blockchain are ...

New Delhi, Feb. 07, 2025 (GLOBE NEWSWIRE) -- The global pharmaceutical packaging market valuation is poised to reach US$ 464.4 billion by 2031, with a CAGR of 14.8% during the forecast period.

An illustration of the potential is evident in forecasts that the global healthcare data storage market will grow from $4.17 billion in 2021 to $9.23 billion by 2026, according to research by the ...

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various factors.

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Adoption of CRM to streamline clinical data ... In Pharma Biotech Sectors AI CRM is poised to grow at the highest CAGR of 18.4% in the years to come in the pharma & biotech CRM software market.

With pharmaceutical companies heavily investing in R&D and precision medicine, the demand for high-quality specialty APIs is ...

With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

Industry associations react to President Trump’s tariffs and what they could mean for the pharmaceutical supply chain.

CEO Jan Mikkelsen highlighted 2024 as a pivotal year, with SKYTROFA achieving €200 million in revenue and a 6.5% share of the U.S. growth hormone market. The product now holds 45% of the U.S.